Karyosoft Inc. is a biotechnology and information technology startup based in the United States, founded in 2017. The company's slogan "In-House No-Code Genomics Platform helping Geneticists for Enhanced Research Efficiency and Accelerated Innovations" reflects its focus on providing a secure, no-code genomics data management, analytics, and visualization platform for molecular geneticists and bioinformaticians. This platform aims to enhance research efficiency and accelerate innovations in agrigenomics and life sciences organizations. Karyosoft Inc. offers no-code genomics software solutions to address the common challenges faced by geneticists and bioinformaticians in their Next-Generation Sequencing (NGS) workflow, particularly in secondary and tertiary analyses. The company's platforms have demonstrated value creation for life scientists and their organizations by saving time and costs, accelerating time to market, and providing higher data integrity by serving as a central data repository. The startup recently secured a Seed Round investment of $30.00K on 15 September 2020, with Health Wildcatters being the investors. This investment is intended to further the company's mission of revolutionizing genomics research and driving innovation in the biotechnology and information technology industries. Karyosoft's innovative approach to genomics data management positions it as a promising player in the rapidly evolving biotechnology landscape.
No recent news or press coverage available for Karyosoft Inc..